简体中文
|
繁體中文
|
English
Business Wire Global sites
Business Wire Global
UK/Ireland
Deutschland
France
Italy
Japan
Home
News
Events
Media Services
About Us
Contact Us
Health and Pharmaceutical Press Releases
2024-06-14 16:29
Celltrion showcases promising results in phase III study for CT-P47, a biosimilar candidate of RoActemra® (tocilizumab) in patients with rheumatoid arthritis (RA) at EULAR 2024
2024-06-13 11:26
RegenLab France Receives Prestigious EU-EIB Innovation Champion Award
2024-06-13 11:17
GSK Enters Into a Multi-Year Data Licence Agreement With Ochre Bio to Further Investigate the Drivers of Liver Disease
2024-06-11 13:22
Hematology/Oncology: AOP Health’s Expanding Clinical Research Program Delivers New Results
2024-06-07 09:54
Erbe Elektromedizin inaugurates new competence center for medical instruments in Rangendingen, Germany, and expands its capacities for customers all over the world
2024-06-05 10:33
Bio-Sourcing and Afrigen Biologics partner on groundbreaking biomanufacturing platform to improve access to biotherapeutics in South Africa
2024-06-05 10:23
Philip Morris International Tops Forbes’ 2024 Net Zero Leaders List
2024-06-05 10:08
OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology
2024-06-04 10:16
Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
2024-06-04 10:08
Merck’s Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment
2024-06-04 10:03
Germans Trias i Pujol Hospital in Spain Launches Telehealth and Remote Patient Management Program Using Masimo W1® Medical Watches and Radius VSM™ Wearable Continuous Vital Signs Monitors
2024-06-03 13:00
Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
2024-06-03 09:55
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
2024-06-03 09:51
Takeda Receives Positive CHMP Opinion for Recombinant ADAMTS13 (rADAMTS13) in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2024-05-31 16:31
Morinaga Milk’s New Research Breakthrough Backed the Superiority of its Human-Residential Bifidobacteria (HRB) Strains in Metabolizing Toxin Precursor in the Gut
2024-05-31 15:18
Quit Like Sweden Urges Progressive Tobacco Control to Save Millions of Lives on World No Tobacco Day
2024-05-31 11:00
Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing
2024-05-31 10:00
Rhea Launches with Senior Advisory Panel, Growth Acquisitions and Strategic Partnerships to Advance Fertility Journeys for the Modern Family
2024-05-30 10:25
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
2024-05-30 10:00
We Are Innovation and Anglo-American University Hosted the Exclusive Premiere of "How Sweden Quit Smoking"
<< First
< Previous
17
18
19
20
21
22
23
24
25
26
Next >
Last >>
57047
57037
57035
57008
56993
56972
56971
56969
56962
56959
56958
56954
56943
56942
56938
56937
56935
56924
56916
56912
Business Wire Weibo
Press Releases
Corporate Social Responsibility
Manufacturing
Chemical
Health and Pharmaceutical
Property
Travel
Automotive
Life and Entertainment
Energy and Environmental
Retail
Transportation
Business and E-commerce
Communications and Media
Metals and Mining
Finance
Technology
Sports
Education
Art and Culture
Legal
Latest Releases
2025-06-12 16:29
China Wins Two Global Water Awards for Breakthroughs in Sustainable Desalination
2025-06-12 16:19
Board Reimagines the Planner Experience with AI-Powered Agents
2025-06-12 16:16
ExaGrid Wins 2 New Industry Awards at the Storage Awards
2025-06-12 16:09
Ben Mauro's Sci-Fi Epic 'HUXLEY' Launches Globally with Hardcover & Softcover Editions; New Trailer and Prequel 'The Oracle' Announced for October Release
2025-06-12 15:40
LevelBlue Agrees to Acquire Aon’s Cybersecurity & IP Litigation Consulting Groups